E3024 is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes

被引：0
|
作者：
Yasuda, Nobuyuki
Nagakura, Tadashi
Inoue, Takashi
Yamazaki, Kazuto
Katsutani, Naruo
Takenaka, Osamu
Clark, Richard
Matsuura, Fumiyoshi
Emori, Eita
Yoshikawa, Seiji
Kira, Kazunobu
Okada, Toshimi
Ikuta, Hironori
Saeki, Takao
Asano, Osamu
Tanaka, Isao
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [1] Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (04) : 402 - 413
  • [2] Alogliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Glode, Ashley
    Abdelghany, Sam
    FORMULARY, 2008, 43 (09) : 317 - +
  • [3] Vildagliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (10) : 494 - +
  • [4] ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity
    Matsuyama-Yokono, Akiko
    Tahara, Atsuo
    Nakano, Ryosuke
    Someya, Yuka
    Nagase, Itsuro
    Hayakawa, Masahiko
    Shibasaki, Masayuki
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (01) : 98 - 107
  • [5] The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin
    Hamasaki, Hidetaka
    Yanai, Hidekatsu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : E106 - E106
  • [6] Dipeptidyl peptidase-IV inhibitors: fixing type 2 diabetes?
    McIntyre, Hugh F.
    Grant, Paul
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (11) : 599 - 602
  • [7] RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes
    Singh, Shuchita
    Sethi, Sachin
    Khanna, Vivek
    Benjamin, Biju
    Kant, Rajiv
    Sattigeri, Jitendra
    Bansal, Vinay S.
    Bhatnagar, Pradip Kumar
    Davis, Joseph Alex
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 652 (1-3) : 157 - 163
  • [8] Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo
    Yuka Someya
    Atsuo Tahara
    Ryosuke Nakano
    Akiko Matsuyama-Yokono
    Itsuro Nagase
    Yasuhisa Fukunaga
    Toshiyuki Takasu
    Masahiko Hayakawa
    Masayuki Shibasaki
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377 : 209 - 217
  • [9] Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Gallwitz, Baptist
    IDRUGS, 2008, 11 (12) : 906 - 917
  • [10] Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo
    Someya, Yuka
    Tahara, Atsuo
    Nakano, Ryosuke
    Matsuyama-Yokono, Akiko
    Nagase, Itsuro
    Fukunaga, Yasuhisa
    Takasu, Toshiyuki
    Hayakawa, Masahiko
    Shibasaki, Masayuki
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 (03) : 209 - 217
12345